ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Contact us Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Satisfying unmet medical needs Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Oncology / Haematology Multiple myeloma Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Transparency Disclosure Bringing new medicines to patients with unmet medical need is built on collaborations between healthcare professionals and the pharmaceutical industry. To improve health outcome the industry is dependent on the invaluable work done by practitioners to improve both care and treatment options. A healthy transparent working relationship between the industry and healthcare professionals/organisations is relying on transparency when it comes to disclosure of payments made to healthcare professionals. Immedica will on this page when applicable disclose payments for attendance, sponsorships, speaker fees and other consultancy fees. In some countries the authority’s has local databases where it is mandatory to disclose the above and Immedica will follow local regulations. Czech Republic Disclosure for payments made to HCP/HCO DACH Disclosure for payments made to HCP/HCO Norway Disclosure for payments made to HCP/HCO Polen Disclosure for payments made to HCP/HCO Spain Disclosure for payments made to HCP/HCO Sweden Disclosure for payments made to HCP/HCO UK Disclosure for payments made to HCP/HCO Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Safety and product complaints Patient safety is a priority for Immedica. Suspected adverse drug reactions associated with medicinal products supplied by Immedica, should be reported to Regulatory Authorities according to national requirements. In addition, you may contact Immedica Drug Safety at: If you would like to report a product complaint, i.e. a problem with a medical product supplied by Immedica, this should be reported according to national requirements and primarily to your local pharmacy. You may also contact Immedica Quality at: Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica